{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T11:46:04.473049+00:00","published_at":"2026-10-17T04:46:59.013572+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:sjh32d1ibckbz","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-31","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:austin-charette","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:45fdfc845cf1ff86db6d8f5d6d9d283cbc8f4fdaa6536c82a7fdf3225089723a"],"summary":"Austin Charette executive of MiNK Therapeutics, Inc., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:tvgdf4w58ba0","event_type":"CEO_CHANGED","effective_at":"2026-03-31","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:jennifer-s-buell-ph-d","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:788360057fa64a21a4c5a4511c1cd38ef7df4d2a7280f6c577d17a738b9bf5f2"],"summary":"Jennifer S. Buell, Ph.D. executive of MiNK Therapeutics, Inc., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1guy7o017wmpgw","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-31","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:melissa-orilall","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:db66cc4281585382ca9bf2ec4bbef6ddc4f849d66975f60c55c297896a963b4c"],"summary":"Melissa Orilall executive of MiNK Therapeutics, Inc., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:13nw6ew1u6pd40","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:robert-kadlec","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Robert Kadlec seat on MiNK Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1se0zxh1g7735d","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:barbara-ryan-2","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Barbara Ryan seat on MiNK Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:xex3limcwwbk","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:jennifer-buell-ph-d","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Jennifer Buell, Ph.D. seat on MiNK Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18q8vxp1upk9qt","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:peter-behner","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Peter Behner seat on MiNK Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:renpopyhvt91","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:committee:mink-therapeutics-inc:audit-nominating-and-governance-chair","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Audit; Nominating and Governance · Chair committee of MiNK Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mtikxb1ai24v3","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:peter-behner","alpha:committee:mink-therapeutics-inc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Peter Behner member of Audit; Nominating and Governance · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1j6vvn1it35gz","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:brian-corvese","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Brian Corvese seat on MiNK Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1l9wq0amsixqm","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:garo-h-armen-ph-d","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Garo H. Armen, Ph.D. seat on MiNK Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hzrhfp9d94rl","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:ulf-wiinberg","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Ulf Wiinberg seat on MiNK Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16924wz5f06av","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:committee:mink-therapeutics-inc:audit-compensation-chair-nominating-and-governance","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Audit; Compensation · Chair; Nominating and Governance committee of MiNK Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fxny4o1x239b8","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:brian-corvese","alpha:committee:mink-therapeutics-inc:audit-compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Brian Corvese member of Audit; Compensation · Chair; Nominating and Governance, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:nva5hle3gk41","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:committee:mink-therapeutics-inc:compensation-chair","alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Compensation · Chair committee of MiNK Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1lx5kuk22lvw4","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:59.013572+00:00","subject_ids":["alpha:person:ulf-wiinberg","alpha:committee:mink-therapeutics-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933"],"summary":"Ulf Wiinberg member of Compensation · Chair, effective 2017-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:5","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:barbara-ryan-2","object_label":"Barbara Ryan","object_source_name_forms":[],"value":"Barbara Ryan: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:barbara-ryan-2","name":"Barbara Ryan"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MiNK Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:31:00.423+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:6","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:brian-corvese","object_label":"Brian Corvese","object_source_name_forms":[],"value":"Brian Corvese: Director, Audit; Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:brian-corvese","name":"Brian Corvese"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MiNK Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:31:00.423+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:7","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:garo-h-armen-ph-d","object_label":"Garo H. Armen, Ph.D.","object_source_name_forms":[],"value":"Garo H. Armen, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:garo-h-armen-ph-d","name":"Garo H. Armen, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MiNK Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:31:00.423+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:8","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jennifer-buell-ph-d","object_label":"Jennifer Buell, Ph.D.","object_source_name_forms":[],"value":"Jennifer Buell, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jennifer-buell-ph-d","name":"Jennifer Buell, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MiNK Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:31:00.423+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:9","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-behner","object_label":"Peter Behner","object_source_name_forms":[],"value":"Peter Behner: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-behner","name":"Peter Behner"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MiNK Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:31:00.423+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:10","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-kadlec","object_label":"Robert Kadlec","object_source_name_forms":[],"value":"Robert Kadlec: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robert-kadlec","name":"Robert Kadlec"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MiNK Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:31:00.423+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:11","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ulf-wiinberg","object_label":"Ulf Wiinberg","object_source_name_forms":[],"value":"Ulf Wiinberg: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ulf-wiinberg","name":"Ulf Wiinberg"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MiNK Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:31:00.423+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:12","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:austin-charette","object_label":"Austin Charette","object_source_name_forms":[],"value":"Austin Charette: Principal Accounting Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:austin-charette","name":"Austin Charette"},"title":"Principal Accounting Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:45fdfc845cf1ff86db6d8f5d6d9d283cbc8f4fdaa6536c82a7fdf3225089723a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INKT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526134813/inkt-20251231.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:33.224947+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:13","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jennifer-s-buell-ph-d","object_label":"Jennifer S. Buell, Ph.D.","object_source_name_forms":[],"value":"Jennifer S. Buell, Ph.D.: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jennifer-s-buell-ph-d","name":"Jennifer S. Buell, Ph.D."},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:788360057fa64a21a4c5a4511c1cd38ef7df4d2a7280f6c577d17a738b9bf5f2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INKT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526134813/inkt-20251231.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:32.05173+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5638df2f-6c34-4574-8c3a-157c4b9235c0:leadership_role:14","subject_id":"alpha:company:5638df2f-6c34-4574-8c3a-157c4b9235c0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:melissa-orilall","object_label":"Melissa Orilall","object_source_name_forms":[],"value":"Melissa Orilall: Principal Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:melissa-orilall","name":"Melissa Orilall"},"title":"Principal Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-17T04:46:59.013572+00:00","sources":[{"id":"alpha:projection-evidence:document:db66cc4281585382ca9bf2ec4bbef6ddc4f849d66975f60c55c297896a963b4c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INKT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526134813/inkt-20251231.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:32.662881+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:0c61aa726640420bb29e22638d27d6e22521a9f580202bf31ec91d64aac13933","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MiNK Therapeutics, Inc. DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025061041/mink-def_14a_2025.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:31:00.423+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:45fdfc845cf1ff86db6d8f5d6d9d283cbc8f4fdaa6536c82a7fdf3225089723a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INKT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526134813/inkt-20251231.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:33.224947+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:788360057fa64a21a4c5a4511c1cd38ef7df4d2a7280f6c577d17a738b9bf5f2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INKT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526134813/inkt-20251231.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:32.05173+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:db66cc4281585382ca9bf2ec4bbef6ddc4f849d66975f60c55c297896a963b4c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INKT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526134813/inkt-20251231.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:32.662881+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.836,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.9,"cross_source_agreement":0.75,"temporal_completeness":0.526},"diagnostics":{"published_claims":26,"factual_claims":26,"claims_with_linked_evidence":26,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":19,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:59.013572+00:00","observed_at":"2026-10-17T04:46:59.013572+00:00","reviewed_at":"2026-10-17T04:46:59.013572+00:00","verified_at":"2026-10-17T04:46:59.013572+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/mink-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/mink-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}